Albertsons rolls out in-store AI diabetic retinopathy tests

With the launch of artificial intelligence-powered diabetic retinopathy eye exams at its in-store CarePortMD clinics in Delaware and Pennsylvania, Albertsons has become the first retailer to offer the diagnostic technology.

The clinics, located in five Albertsons locations — four Acme Markets grocery stores and one Safeway — now use the FDA-approved IDx-DR system. The AI technology works completely autonomously to identify patients with diabetic retinopathy and macular edema, diabetes-related complications and leading causes of blindness.

Results of the exam, along with patient vitals and other health information, are immediately transmitted from the CarePortMD clinic to the patient's physician.

"What I'm most excited about is that the retinal exam provides a rich source of information, helping to identify patients who are at highest risk for complications of diabetes," Ashok Subramanian, MD, CEO of CarePortMD, said in a news release. "If we catch these high-risk patients earlier, it can result in significant savings for the healthcare system and better patient outcomes."

More articles on consumerism:
15 patient engagement IT tools leading 2020 investment
AtlantiCare receives $50K from Horizon BCBS for patient ridesharing program
Propeller Health expands access to in-app pharmacy services from CVS, Walmart & more

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers